Mesogastrium Metastasis in Colon Cancer
ConditionColon Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-75
SponsorJichao Qin
About this trial
Complete mesocolic excision is currently recognized as a standard procedure for colon cancer. Controversy remains on the presence of right gastroepiploic mesentery metastasis in patients with colon cancer locating at or close to the hepatic flexure. The investigators design this study in order to define the incidence of mesogastrium metastasis and analyse the safety and surgical outcome in these patients who undergo complete mesocolic excision with right gastroepiploic mesentery resection.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age between 18 and 75 years
American Society of Anesthesiologists (ASA) score I to III
A biopsy proven histological diagnosis of colorectal carcinoma
Preoperative staging cT2-4aN0M0 or cTanyN+M0
Disqualifiers
Synchronous colorectal carcinoma
Clinical evidence of metastasis
History of colorectal cancer or other malignant tumors
Preoperative staging cT1N0 or cT4bNany
Trial population
Patients hospitalized in the department of GI Surgery of Tongji Hospital
Trial design
Design model
Case-only
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
metastasis rate
the incidence of gastric mesentery metastasis
Time frame
an average of 1 yearSecondary outcomes
1
intraoperative complication
intraoperative complication of complete mesocolic excision plus right gastroepiploic mesentery resection
Time frame
an average of 1 year2
postoperative complication
postoperative complication of complete mesocolic excision plus right gastroepiploic mesentery resection
Time frame
an average of 1 year3
3-year DFS
3-year disease free survival
Time frame
an average of 3 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Jichao Qin
Lead sponsor
Tongji Hospital
Sponsor institution
Source ClinicalTrials.gov